Home » Products » Pharmaceutical Drugs » Gemer 2mg Glimepiride Tablets

Gemer 2mg Glimepiride Tablets

Gemer 2mg Glimepiride Tablets
Gemer 2mg Glimepiride Tablets
Send Inquiry
Product Code : 00209
Price And Quantity
  • Minimum Order Quantity
  • 10000000
  • Unit of Measure
  • Piece/Pieces
  • Price
  • 129 INR
Product Specifications
  • Drug Type
  • Specific Drug
  • Physical Form
  • Tablets
  • Dosage
  • 2 mg
  • Suitable For
  • Adults, Women
Product Description

Gemer - Gemer is a sulfonylurea antidiabetic agent, prescribed for type 2 diabetes. Indications: Gemer is a sulfonylurea antidiabetic agent, prescribed for type 2 diabetes. It works by causing the pancreas to produce insulin. Contraindications: Contraindicated in patients with diabetic ketoacidosis, with or without coma, and hypersensitivity.

Dosage: Adult- PO- Initial- The recommended starting dose is 1-2 mg once daily, with food. Maximum: 2mg/day. Usage: It comes as a tablet to take by mouth, with food.

Precautions: Caution should be exercised in patients with history of liver and kidney disease, ketoacidosis, elderly, during pregnancy and breastfeeding. It may cause drowsiness, dizziness, blurred vision or lightheadedness, do not drive a car or operate machinery while taking Gemer. Avoid alcohol consumption.

Side Effects: Most Common - Low blood sugar, temporary visual impairment and GI disturbances. Miscellaneous - Dizziness, weakness, headache, nausea/vomiting, lightheadedness, confusion and irritability. Warning: Avoid excess dosage. Storage Conditions: Store it at room temperature and in an airtight container. Active ingredients: Glimepiride

Trade Information
  • Payment Terms
  • Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 10000000 Per Week
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

DHEER HEALTHCARE PRIVATE LIMITED
X


DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.